Hormone-sensitive Her-2 Negative Metastatic Breast Cancer

• CLINICAL_TRIALS trial_result · 2018-08-28
  Clinical Trial Update: Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer [Phase 2]

  Phase 2 clinical trial update for MEDI-573 in combination with standard endocrine therapy in hormone-sensitive, HER2-negative metastatic bre…